F.N.B. Corporation (FNB)

bluebird bio Stock Forecast

Stock Price Forecast

The 9 analysts that cover bluebird bio stock have a consensus rating of "Strong Buy" and an average price target of $18.33, which forecasts a 23.35% increase in the stock price over the next year. The lowest target is $16 and the highest is $20.

Price Target: $18.33 (+23.35%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$16	$18.33	$18.5	$20
Change	+7.67%	+23.35%	+24.50%	+34.59%

Analyst Ratings

The average analyst rating for bluebird bio stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Feb '25	Mar '25	Apr '25	May '25	Jun '25	Jul '25
Strong Buy	1	1	2	3	3	4
Buy	3	3	5	5	5	5
Hold	1	1	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	5	5	7	8	8	9

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
David Smith Truist Securities	Truist Securities	Strong Buy Maintains $18 → $18	Strong Buy	Maintains	$18 → $18	+21.13%	Jul 22, 2025
Manuel Navas DA Davidson	DA Davidson	Strong Buy Maintains $17 → $19	Strong Buy	Maintains	$17 → $19	+27.86%	Jul 21, 2025
Timur Braziler Wells Fargo	Wells Fargo	Buy Maintains $18 → $20	Buy	Maintains	$18 → $20	+34.59%	Jul 21, 2025
Kelly Motta Keefe, Bruyette & Woods	Keefe, Bruyette & Woods	Buy Maintains $17 → $19	Buy	Maintains	$17 → $19	+24.50%	Jul 21, 2025
David Smith Truist Securities	Truist Securities	Strong Buy Maintains $17 → $18	Strong Buy	Maintains	$17 → $18	+17.77%	Jul 11, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

1.77B

Increased by 16.96%

from 1.52B

Revenue Next Year

1.93B

Increased by 8.57%

from 1.77B

EPS This Year

1.42

Increased by 11.88%

from 1.27

EPS Next Year

1.68

Increased by 18.46%

from 1.42

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	1.12B	1.23B	1.38B	1.50B	1.52B	1.77B	1.93B	2.10B
Revenue Growth	-3.44%	9.46%	11.80%	8.91%	1.11%	16.96%	8.57%	9.14%
EPS	0.85	1.23	1.22	1.31	1.27	1.42	1.68	1.85
EPS Growth	-26.72%	44.71%	-0.81%	7.38%	-3.06%	11.88%	18.46%	9.67%
Forward PE	-	-	-	-	-	10.46	8.83	8.05
No. Analysts	-	-	-	-	-	9	9	3

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027
High	1.9B	2.0B	2.2B
Avg	1.8B	1.9B	2.1B
Low	1.7B	1.8B	2.0B

Revenue Growth

Revenue Growth	2025	2026	2027
High	22.4%	14.6%	13.5%
Avg	17.0%	8.6%	9.1%
Low	12.8%	3.7%	5.9%

EPS Forecast

EPS	2025	2026	2027
High	1.53	1.84	2.00
Avg	1.42	1.68	1.85
Low	1.32	1.56	1.72

EPS Growth

EPS Growth	2025	2026	2027
High	20.2%	29.3%	18.8%
Avg	11.9%	18.5%	9.7%
Low	4.2%	9.7%	1.9%

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.